EMCAY is a powerful collective of seasoned team members with a unique background in the pharmaceutical and multicultural spheres of influence. Our team has worked on multicultural campaigns for brands such as Enbrel, Gilenya, Revlimid, Repatha, Prolia, Ozempic, Vytorin, Diovan, Exforge, Victoza, Gardisil, Atripla, Reytaz, Isentress, Zocor, Exelon Patch, Reclast, to name a few.
Our network within the pharmaceutical and multicultural market is specifically designed to empower clients with ideas and strategies that deliver exceptional outcomes.
ABOUT OUR PRESIDENT AND CHIEF STRATEGY OFFICER
In 2014, Steve Millerman was named PM360 Marketer of the Year as the game-changing player in pharmaceutical, biotech, and medical device marketing for his impact on the analytics and methodologies used by the pharmaceutical industry - transforming how today’s multicultural consumer is integrated into the overall strategy.
Prior to EMCAY, Steve was on the client side, managing $30 million to $5 billion brands. In his most recent client position, as head of cross-cultural marketing at Novartis Pharmaceuticals, he built the multicultural capability across all brands and US cultural groups including Hispanic, Asian, Eastern European and African American markets.
The team has been recognized as key influencers and KOLS within the pharmaceutical marketplace for their multicultural work:
Bringing to market some of the largest and most successful pharma multicultural campaigns in the industry
Featured at such events as the DTC National and DTC Multicultural Health Conferences, Portada Hispanic Advertising Conference, the Association of National Advertisers (ANA) and Diversity Inc, Innovation Fest